Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Adenocarcinoma

Explore clinical trials studying Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

201 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma trial results

Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details
Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07491445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Recruiting

Pancreatic Cancer Detection Consortium

NCT06388967

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Translational Genomics Research Institute Phoenix, Arizona, United States
  • Honorhealth Scottsdale, Arizona, United States
  • City of Hope Medical Center Monrovia, California, United States
  • Hoag Center Newport Beach, California, United States
View Trial Details
Recruiting

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

NCT05365581

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +5 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica Santa Monica, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View all 46 locations
View Trial Details
Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT05877599

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Santa Monica, California, United States
View all 18 locations
View Trial Details
Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions